Feasibility of using megavoltage computed tomography to reduce proton range uncertainty: A simulation study.


Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
Mar 2021
Historique:
revised: 10 01 2021
received: 03 12 2019
accepted: 11 01 2021
pubmed: 21 2 2021
medline: 22 6 2021
entrez: 20 2 2021
Statut: ppublish

Résumé

To demonstrate that variation in chemical composition has a negligible effect on the mapping curve from relative electron density (RED) to proton stopping power ratio (SPR), and to establish the theoretical framework of using Megavoltage (MV) computed tomography (CT), instead of kilovoltage (kV) dual energy CT, to accurately estimate proton SPR. A simulation study was performed to evaluate the effect of chemical composition variation on kVCT number and proton SPR. The simulation study involved both reference and simulated human tissues. The reference human tissues, together with their physical densities and chemical compositions, came from the ICRP publication 23. The simulated human tissues were created from the reference human tissues assuming that elemental percentage weight followed a Gaussian distribution. For all tissues, kVCT number and proton SPR were obtained through (a) theoretical calculation from tissue's physical density and chemical composition which served as the ground truth, and (b) estimation from RED using the calibration curves established from the stoichiometric method. Deviations of the estimated values from the calculated values were quantified as errors in using RED to estimate kVCT number and proton SPR. Given a chemical composition variation of 5% (1σ) of the nominal percentage weights, the total estimation error of using RED to estimate kVCT number was 0.34%, 0.62%, and 0.77% and the total estimation error of using RED to estimate proton SPR was 0.30%, 0.22%, and 0.16% for fat tissues, non-fat soft tissues and bone tissues, respectively. Chemical composition had a negligible effect on the method of using RED to determine proton SPR. RED itself is sufficient to accurately determine proton SPR. MVCT number maintains a superb linear relationship with RED because it is highly dominated by Compton scattering. Therefore, MVCT has great potential in reducing the proton range uncertainty.

Identifiants

pubmed: 33608992
doi: 10.1002/acm2.13191
pmc: PMC7984486
doi:

Substances chimiques

Protons 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-140

Subventions

Organisme : Matteson Funds

Informations de copyright

© 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.

Références

Int J Radiat Oncol Biol Phys. 1992;22(2):383-9
pubmed: 1740396
Phys Med Biol. 2008 May 7;53(9):2327-44
pubmed: 18421122
Cancer Res. 1958 Feb;18(2):121-34
pubmed: 13511365
Phys Med Biol. 1996 Jan;41(1):111-24
pubmed: 8685250
Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1429-38
pubmed: 11286851
Phys Med Biol. 2011 Jul 21;56(14):4499-515
pubmed: 21719949
Phys Med Biol. 2009 Jun 7;54(11):N205-15
pubmed: 19436099
Med Phys. 2013 Aug;40(8):081709
pubmed: 23927306
Phys Med Biol. 2008 Feb 21;53(4):1027-42
pubmed: 18263956
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):523-533
pubmed: 26725727
Phys Med Biol. 2010 Mar 7;55(5):1343-62
pubmed: 20145291
Med Phys. 2018 May;45(5):2129-2142
pubmed: 29570809
J Appl Clin Med Phys. 2017 Nov;18(6):88-96
pubmed: 28921881
Strahlenther Onkol. 1999 Jun;175 Suppl 2:57-63
pubmed: 10394399
Med Phys. 2020 Feb;47(2):745-752
pubmed: 31758864
Head Neck. 2016 Apr;38 Suppl 1:E1886-95
pubmed: 26705956
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1596-606
pubmed: 15050341
Br J Radiol. 2020 Mar;93(1107):20190590
pubmed: 31642709
Phys Med Biol. 2012 Jul 7;57(13):4095-115
pubmed: 22678123
Z Med Phys. 2013 Dec;23(4):300-13
pubmed: 23597413
Phys Med Biol. 1998 Jun;43(6):1579-92
pubmed: 9651027
Phys Med Biol. 2008 Feb 21;53(4):1043-56
pubmed: 18263957

Auteurs

Yanle Hu (Y)

Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.

Xiaoning Ding (X)

Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.

Jiajian Shen (J)

Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.

Martin Bues (M)

Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.

Wei Liu (W)

Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.

Yixiu Kang (Y)

Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.

Shuai Leng (S)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Lifeng Yu (L)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH